ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/N-Fmoc-4-Cyclopropyl-L-phenylalanine
C27H25NO4
427.5 g/mol
Pharmaceutical Intermediate

N-Fmoc-4-Cyclopropyl-L-phenylalanine

CAS1997389-26-0
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

N-Fmoc-4-Cyclopropyl-L-phenylalanine, abbreviated as Fmoc-Phe(cPr)(cPr)-OH, is a protected amino acid used in solid-phase peptide synthesis. The compound features a fluorenylmethoxycarbonyl (Fmoc) group for temporary N-terminal protection and a cyclopropyl-substituted phenylalanine side chain.

Protected amino acid for peptide synthesisBuilding block for research peptides containing cyclopropylphenylalanine residues

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing N-Fmoc-4-Cyclopropyl-L-phenylalanine?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

HCV-IN-31

CAS1998705-62-6

pharmaceutical intermediate

ReferenceSame Category

(S)-2-(2-Hydroxyethyl)piperidine-1-carboxylic acid tert-butyl ester

CAS199942-74-0

pharmaceutical intermediate

ReferenceSame Category

(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine 4-methylbenzenesulfonate

CAS200000-59-5

pharmaceutical intermediate

ReferenceSame Category

5-(4-Bromophenyl)furfural

CAS20005-42-9

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S)-3-(4-cyclopropylphenyl)-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid

InChIKey

ZTZNBIYOPCMABQ-VWLOTQADSA-N

SMILES

C1CC1C2=CC=C(C=C2)C[C@@H](C(=O)O)NC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35

Synonyms (4)
  • Fmoc-Phe(4-Cyclopropyl)-OH

Sourcing N-Fmoc-4-Cyclopropyl-L-phenylalanine?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→